| Q98945346 | "Mastering a New Life Situation" - Patients' Preferences of Treatment Outcomes in Early Rheumatoid Arthritis - A Longitudinal Qualitative Study |
| Q55252682 | A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis. |
| Q36701988 | Acceptance of New Technology: A Usability Test of a Computerized Adaptive Test for Fatigue in Rheumatoid Arthritis |
| Q38895581 | Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways |
| Q38880616 | Arthritis and cognitive impairment in older adults. |
| Q89601177 | Association between vitamin D and fatigue in patients with rheumatoid arthritis: a cross-sectional study |
| Q57167038 | Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis |
| Q36307599 | Associations of perceived social support and positive psychological resources with fatigue symptom in patients with rheumatoid arthritis |
| Q38212141 | Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries |
| Q47669040 | Changes in the clinical presentation of patients with rheumatoid arthritis from the early 1990s to the years 2010: earlier identification but more severe patient reported outcomes. |
| Q84578241 | Cognitive-behavioural approaches to self-management in rheumatic disease |
| Q53437721 | Cognitive-behavioural therapy (CBT) for renal fatigue (BReF): a feasibility randomised-controlled trial of CBT for the management of fatigue in haemodialysis (HD) patients. |
| Q35879635 | Construct Validation of a Multidimensional Computerized Adaptive Test for Fatigue in Rheumatoid Arthritis |
| Q36215816 | Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis |
| Q48079611 | Determining Pathways to Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis |
| Q47687442 | Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature. |
| Q38645799 | Effects of exercise on physical limitations and fatigue in rheumatic diseases |
| Q54977014 | Estrogen weakens muscle endurance via estrogen receptor-p38 MAPK-mediated orosomucoid (ORM) suppression. |
| Q38647146 | Exploring the patient perspective of fatigue in adults with visual impairment: a qualitative study |
| Q64999260 | Factors of importance for reducing fatigue in persons with rheumatoid arthritis: a qualitative interview study. |
| Q36220823 | Factors that influence fatigue status in patients with severe rheumatoid arthritis (RA) and good disease outcome following 6 months of TNF inhibitor therapy: a comparative analysis |
| Q41170483 | Fatigue - an underestimated symptom in psoriatic arthritis |
| Q47877524 | Fatigue in Arthritis: A Multidimensional Phenomenon with Impact on Quality of Life : Fatigue and Quality of Life in Arthritis. |
| Q39225796 | Fatigue in Rheumatoid Arthritis |
| Q37028931 | Fatigue in adults with traumatic brain injury: predictors and consequences. A systematic review of longitudinal study protocols. |
| Q26782282 | Fatigue in chronic inflammation - a link to pain pathways |
| Q90264892 | Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study |
| Q33421555 | Fatigue in immune thrombocytopenia |
| Q28079588 | Fatigue in rheumatic diseases |
| Q36182368 | Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study |
| Q55098455 | Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients. |
| Q39568753 | Fatigue, pain and patient global assessment responses to biological treatment are unpredictable, and poorly inter-connected in individual rheumatoid arthritis patients followed in the daily clinic |
| Q45004190 | Health-related quality of life and depression in a sample of Latin American adults with rheumatoid arthritis. |
| Q50646226 | Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients. |
| Q33725521 | Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept |
| Q40195611 | In rheumatoid arthritis, country of residence has an important influence on fatigue: results from the multinational COMORA study |
| Q35808109 | Increased Th17/Treg Ratio in Poststroke Fatigue |
| Q40926392 | Interplay between patient global assessment, pain, and fatigue and influence of other clinical disease activity measures in patients with active rheumatoid arthritis |
| Q47181008 | Metabolomic markers of fatigue: Association between circulating metabolome and fatigue in women with chronic widespread pain |
| Q52632442 | Multidimensional fatigue in pulmonary hypertension: prevalence, severity and predictors. |
| Q60584959 | Neural Indicators of Fatigue in Chronic Diseases: A Systematic Review of MRI Studies |
| Q47692825 | Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis |
| Q47357520 | Neuromuscular fatigue is weakly associated with perception of fatigue and function in patients with rheumatoid arthritis |
| Q38621244 | Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue |
| Q41595008 | Patient's perspective of sustained remission in rheumatoid arthritis |
| Q64106266 | Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study |
| Q26778271 | Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis |
| Q58576273 | Perceived Versus Performance Fatigability in Patients With Rheumatoid Arthritis |
| Q41134158 | Predictors of Fatigue in Rheumatoid Arthritis Patients in Remission or in a Low Disease Activity State |
| Q33442266 | Predictors of fatigue among individuals with primary immune thrombocytopenia in China |
| Q92762252 | Predictors of fatigue in rheumatoid arthritis |
| Q94584801 | Predictors of pain in general ageing populations: results from a multi-country analysis based on ATHLOS harmonized database |
| Q37058278 | Psychometric Evaluation of the Patient-Reported Outcomes Measurement Information System Fatigue-Short Form Across Diverse Populations |
| Q91825164 | Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT) |
| Q41206422 | Role of Sleep Disturbance, Depression, Obesity, and Physical Inactivity in Fatigue in Rheumatoid Arthritis |
| Q44791359 | Safety and feasibility of maximal physical testing in rheumatic diseases: a cross-sectional study with 5,910 assessments |
| Q37704288 | Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors |
| Q58735831 | Sarilumab: patient-reported outcomes in rheumatoid arthritis |
| Q35914878 | Seasonal variations in fatigue in persons with rheumatoid arthritis: a longitudinal study. |
| Q38731956 | Sedentary behaviour in rheumatoid arthritis: definition, measurement and implications for health |
| Q93103600 | Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis - Results of a cross-sectional study |
| Q64936096 | The association of pain and stiffness with fatigue in incident polymyalgia rheumatica: baseline results from the polymyalgia rheumatica cohort study. |
| Q48075422 | The burden of disease in rheumatoid arthritis |
| Q28396869 | The burden of musculoskeletal conditions |
| Q35123232 | The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis |
| Q92464809 | The extra-articular impacts of rheumatoid arthritis: moving towards holistic care |
| Q92762160 | The impact of fatigue in rheumatoid arthritis and the challenges of its assessment |
| Q90654824 | The relationship between bristol rheumatoid arthritis fatigue scales and disease activity of patients with rheumatoid arthritis |
| Q47552446 | The relationship between work, mental health, physical health, and fatigue in patients with rheumatoid arthritis: A cross-sectional study. |
| Q95820931 | The value of embedded secondary-care-based psychology services in rheumatology: an exemplar for long-term conditions |
| Q35643767 | Understanding the Association of Fatigue With Other Symptoms of Fibromyalgia: Development of a Cluster Model |
| Q91797957 | Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT |
| Q40561867 | Variation in fatigue may be poorly explained by pain: results from a longitudinal, exploratory study |